Pharmaceutical Marketers to Spend $2.2 Billion Online in 2011
A Limited View of the Internet Is Hindering the Potential
But when consumers arrive at the advertised site -- and they do in droves -- they often encounter pages of text and a slow to load TV commercial. Having restricted their brand sites to mere online information centers, pharma marketers are missing big opportunities to engage consumers and boost compliance, according to eMarketer's report "Pharmaceutical Marketing Online: Stuck in Web 1.5."
Online advertising spending by the pharmaceutical and healthcare industry will hit $975 million in 2007, a gain of 19% over 2006. By 2011, the pharmaceutical category will account for 5% of US online ad spending, or $2.2 billion.
Pharmaceutical marketers have a rigid view of the Internet as an information-delivery vehicle. But consumers are using the Internet to interact with one another and with brands. Their online experiences help to build or break trust in brands and companies. With consumer attitudes towards drug makers hitting all time lows, trust is sorely needed.
"Messages must be interactive because consumers are looking for a dialogue, especially when their health is involved," says Lisa Phillips, senior analyst and author of the report. "Something as simple as offering mobile or Internet alerts to prompt patients to take their medicine are opt-in tactics that benefit patients and boost compliance."
About eMarketer
eMarketer is "The First Place to Look" for market research information related to the Internet, e-business, online marketing and emerging technologies. eMarketer aggregates and analyzes e-business research from over 2,800 sources, and brings it together in analyst reports, daily research articles and the "eStat Database" -- the most comprehensive database of e-business and online marketing statistics in the world.
Posted: September 2007
- Breo Ellipta Breo Ellipta (fluticasone and vilanterol) is a once-a-day inhaled corticosteroid / long-acting beta2 agonist...
- Suvorexant Suvorexant is a potential new insomnia drug which appears to help people fall asleep without causing next-day...
- Liptruzet Liptruzet (atorvastatin and ezetimibe) is a statin (HMG-CoA reductase inhibitor) and cholesterol absorption...
- Procysbi Procysbi (cysteamine bitartrate) is a cystine depleting agent indicated for the treatment of nephropathic...
- Kcentra Kcentra (prothrombin complex concentrate, human) is a plasma-derived product indicated for the urgent...
- Simbrinza Simbrinza (brimonidine and brinzolamide) is a fixed combination of an alpha 2 adrenergic receptor agonist and...
- Methotrexate Sodium, USP Injectable Vials by Sandoz US: Recall - Particulate Matter In VialsMay 21, 2013
Sandoz is conducting a voluntary nationwide recall to the hospital/user level of two lots of its Methotrexate Sodium, USP, 25 mg/mL, 40 mL vial...
- Abbott Diabetes Care: Class 1 Recall - FreeStyle InsuLinx Blood Glucose Meters - Risk of Incorrect Test ResultMay 20, 2013
Abbott initiated a voluntary recall of FreeStyle lnsulinx Blood Glucose Meters in the United States. At extremely high blood glucose levels...
- All Sterile Drug Products Made and Distributed By NuVision Pharmacy Dallas Facility: Recall - Lack Of Sterility AssuranceMay 18, 2013
FDA is alerting health care providers of concerns about a lack of sterility assurance of all sterile drug products made and distributed by NuVision...
